Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022

Motoko Yanagita^{1

2}, Satoru Muto³, Hiroyuki Nishiyama⁴, Yuichi Ando⁵, Sumio Hirata⁶, Kent Doi⁷, Yutaka Fujiwara⁸, Norio Hanafusa⁹, Takahiro Hatta¹⁰, Junichi Hoshino¹¹, Satoko Ichioka¹², Takamitsu Inoue¹³, Kenji Ishikura¹⁴, Taigo Kato¹⁵, Hiroshi Kitamura¹⁶, Yusuke Kobayashi¹⁷, Yuichi Koizumi¹⁸, Chihiro Kondoh¹⁹, Takeshi Matsubara²⁰, Kazuo Matsubara²¹, Koji Matsumoto²², Yusuke Okuda¹⁴, Yuta Okumura²³, Emiko Sakaida²⁴, Yugo Shibagaki²⁵, Hideki Shimodaira²⁶, Nao Takano²⁷, Akiko Uchida²⁸, Kimikazu Yakushijin²⁹, Takehito Yamamoto³⁰, Kazuhiro Yamamoto³¹, Yoshinari Yasuda³², Mototsugu Oya³³, Hirokazu Okada³⁴, Masaomi Nangaku³⁵, Naoki Kashihara³⁶

Affiliations

¹ Department of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Japan. motoy@kuhp.kyoto-u.ac.jp.
² Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan. motoy@kuhp.kyoto-u.ac.jp.
³ Department of Urology, Graduate School of Medicine, Juntendo University, Bunkyo City, Tokyo, Japan.
⁴ Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
⁵ Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
⁶ Department of Academic Education, I and H Co., Ltd, Ashiya, Japan.
⁷ Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, Bunkyo City, Tokyo, Japan.
⁸ Department of Thoracic Oncology, Aichi Cancer Center, Nagoya, Japan.
⁹ Department of Blood Purification, Tokyo Women's Medical University, Shinjuku City, Tokyo, Japan.
¹⁰ Department of Respiratory Medicine, Anjo Kosei Hospital, Anjo, Japan.
¹¹ Department of Nephrology, Tokyo Women's Medical University, Shinjuku City, Tokyo, Japan.
¹² Department of Pediatrics, Shiga University of Medical Science, Otsu, Shiga, Japan.
¹³ Department of Renal and Urologic Surgery, International University of Health and Welfare Narita Hospital, Chiba, Japan.
¹⁴ Department of Pediatrics, Kitasato University School of Medicine, Minato, Kanagawa, Japan.
¹⁵ Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
¹⁶ Department of Urology, Faculty of Medicine, University of Toyama, Toyama, Japan.
¹⁷ Department of Obstetrics and Gynecology, Keio University School of Medicine, Minato, Tokyo, Japan.
¹⁸ Department of Pharmacy, Seichokai Fuchu Hospital, Izumi, Japan.
¹⁹ Departments of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
²⁰ Department of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
²¹ Department of Pharmacy, Wakayama Medical University Hospital, Wakayama, Japan.
²² Hyogo Cancer Center, Akashi, Hyogo, Japan.
²³ Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
²⁴ Department of Hematology, Chiba University Hospital, Chiba, Japan.
²⁵ Division of Nephrology and Hypertension, Department of Internal Medicine, Saint Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
²⁶ Division of Medical Oncology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
²⁷ Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan.
²⁸ Department of Nursing, Seirei Sakura Citizen Hospital, Chiba, Japan.
²⁹ Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Hyogo, Japan.
³⁰ Department of Pharmacy, The University of Tokyo Hospital, Bunkyo City, Tokyo, Japan.
³¹ Department of Pharmacy, Kobe University Hospital, Kobe, Japan.
³² Department of Nephrology, Internal Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
³³ Department of Urology, Keio University School of Medicine, Minato, Tokyo, Japan.
³⁴ Department of Nephrology, Saitama Medical University, Saitama, Japan.
³⁵ Division of Nephrology and Endocrinology, The University of Tokyo, Bunkyo City, Tokyo, Japan.
³⁶ Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan.

PMID: 38070021
PMCID: PMC10808267
DOI: 10.1007/s10157-023-02436-9

Published Erratum

Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022

Motoko Yanagita et al. Clin Exp Nephrol. 2024 Feb.

. 2024 Feb;28(2):123-124.

doi: 10.1007/s10157-023-02436-9.

Authors

Affiliations

¹ Department of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Japan. motoy@kuhp.kyoto-u.ac.jp.
² Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan. motoy@kuhp.kyoto-u.ac.jp.
³ Department of Urology, Graduate School of Medicine, Juntendo University, Bunkyo City, Tokyo, Japan.
⁴ Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
⁵ Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
⁶ Department of Academic Education, I and H Co., Ltd, Ashiya, Japan.
⁷ Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, Bunkyo City, Tokyo, Japan.
⁸ Department of Thoracic Oncology, Aichi Cancer Center, Nagoya, Japan.
⁹ Department of Blood Purification, Tokyo Women's Medical University, Shinjuku City, Tokyo, Japan.
¹⁰ Department of Respiratory Medicine, Anjo Kosei Hospital, Anjo, Japan.
¹¹ Department of Nephrology, Tokyo Women's Medical University, Shinjuku City, Tokyo, Japan.
¹² Department of Pediatrics, Shiga University of Medical Science, Otsu, Shiga, Japan.
¹³ Department of Renal and Urologic Surgery, International University of Health and Welfare Narita Hospital, Chiba, Japan.
¹⁴ Department of Pediatrics, Kitasato University School of Medicine, Minato, Kanagawa, Japan.
¹⁵ Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
¹⁶ Department of Urology, Faculty of Medicine, University of Toyama, Toyama, Japan.
¹⁷ Department of Obstetrics and Gynecology, Keio University School of Medicine, Minato, Tokyo, Japan.
¹⁸ Department of Pharmacy, Seichokai Fuchu Hospital, Izumi, Japan.
¹⁹ Departments of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
²⁰ Department of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
²¹ Department of Pharmacy, Wakayama Medical University Hospital, Wakayama, Japan.
²² Hyogo Cancer Center, Akashi, Hyogo, Japan.
²³ Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
²⁴ Department of Hematology, Chiba University Hospital, Chiba, Japan.
²⁵ Division of Nephrology and Hypertension, Department of Internal Medicine, Saint Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
²⁶ Division of Medical Oncology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
²⁷ Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan.
²⁸ Department of Nursing, Seirei Sakura Citizen Hospital, Chiba, Japan.
²⁹ Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Hyogo, Japan.
³⁰ Department of Pharmacy, The University of Tokyo Hospital, Bunkyo City, Tokyo, Japan.
³¹ Department of Pharmacy, Kobe University Hospital, Kobe, Japan.
³² Department of Nephrology, Internal Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
³³ Department of Urology, Keio University School of Medicine, Minato, Tokyo, Japan.
³⁴ Department of Nephrology, Saitama Medical University, Saitama, Japan.
³⁵ Division of Nephrology and Endocrinology, The University of Tokyo, Bunkyo City, Tokyo, Japan.
³⁶ Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan.

PMID: 38070021
PMCID: PMC10808267
DOI: 10.1007/s10157-023-02436-9

No abstract available

PubMed Disclaimer

Erratum for

Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022.
Yanagita M, Muto S, Nishiyama H, Ando Y, Hirata S, Doi K, Fujiwara Y, Hanafusa N, Hatta T, Hoshino J, Ichioka S, Inoue T, Ishikura K, Kato T, Kitamura H, Kobayashi Y, Koizumi Y, Kondoh C, Matsubara T, Matsubara K, Matsumoto K, Okuda Y, Okumura Y, Sakaida E, Shibagaki Y, Shimodaira H, Takano N, Uchida A, Yakushijin K, Yamamoto T, Yamamoto K, Yasuda Y, Oya M, Okada H, Nangaku M, Kashihara N. Yanagita M, et al. Clin Exp Nephrol. 2024 Feb;28(2):85-122. doi: 10.1007/s10157-023-02415-0. Epub 2023 Oct 25. Clin Exp Nephrol. 2024. PMID: 37878114 Free PMC article. No abstract available.

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022

Affiliations

Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources